The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

A lack of vaccination against respiratory pathogens was commonly identified among US international travelers, indicating the need to improve vaccine uptake at pre-travel visits.

EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults “Pneumococcal disease continues to pose a significant risk for adults in Europe, among adults who are ...

Amid the growing importance of pneumococcal vaccination to prevent pneumonia during the change of seasons, confusion is ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

Pneumococcal infections can be very serious – they include pneumonia, meningitis, and bacteremia (a blood infection), as well as usually less worrying ear infections and sinus infections.

Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults, Merck & Co has reported positive trial results in children that will ramp up the pressure on Pfizer and ...

Vaccinations are key amid recent measles outbreaks in the U.S., including Michigan. Here's a look at what to know.

We all remember dreading doctor’s appointments as kids, because we never knew when we were due for a scheduled vaccination. As adults we can still lose track of which recommended vaccines we ...

The Centers for Disease Control and Prevention is expected to hand over multiple sets of vaccine safety data to a discredited researcher with a history of spreading misinformation that vaccines ...

Health and Human Services Secretary Robert F. Kennedy Jr. this week made his strongest endorsement yet of the measles vaccine amid an ongoing outbreak that has killed three and infected more than ...

On March 10, Dr. Nisha Acharya got a letter from the National Institutes of Health terminating her grant to study the safety and effectiveness of a vaccine recommended for all adults 50 and older ...